iifl-logo

PGIM India Healthcare Fund Regular G

PGIM India Healthcare Fund Regular G

Fund Name

:  PGIM India Mutual Fund

Scheme Name

:  PGIM India Healthcare Fund Regular G

AMC

:  PGIM India Mutual Fund

Type

:  Open

Category

:  Equity - Pharma

Launch Date

:  19-Nov-2024

Fund Manager

:  Anandha Padmanabhan Anjen

Net Assets (Rs. cr)

:  142.13

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

PGIM India Healthcare Fund Regular G - Nav Details

Nav Date

:  19-Nov-2026

NAV [Rs.]

:  12.52

Buy/Resale Price [Rs.]

:  0

Sell/Repurchase Price [Rs.]

:  0

Entry Load %

:  Nil

Exit Load %

:  For Exits within 90 days from date of allotment of units: 0.50% For Exits beyond 90 days from date of allotment of units: NIL

PGIM India Healthcare Fund Regular G- NAV Chart

PGIM India Healthcare Fund Regular G- Performance(%)

Returns above 1 yr. are annualized

1W
1M
3M
6M
1Y
3Y
5Y
Since INC
Scheme Returns
0.07
11.09
2.87
15.17
24.32
-
-
12.19
Category Avg
-0.29
10.57
3.23
12.2
19.77
20.76
16
17.23
Category Best
1.04
18.33
7.79
19.06
33.09
30.64
20.7
31.42
Category Worst
-1.35
6.67
-0.34
5.61
4.98
15.19
13.22
6.09

PGIM India Healthcare Fund Regular G- Latest Dividends

No Records Found

PGIM India Healthcare Fund Regular G- Investment Details

Min. Investment(Rs.)

:  5000

Increm.Investment(Rs.)

:  1000

In & Out

In

InName Of The CompanyNo Of Shares
--

Out

InName Of The CompanyNo Of Shares
--

Fund Holdings

Asset Type
Instrument Name
Industry
Net Assets(%)
No of Shares
Mkt Value(Cr.)
Equity & Equity related Investments
EquityDivi's Lab.Pharmaceuticals & Biotechnology11.081609915.74
EquitySun Pharma.Inds.Pharmaceuticals & Biotechnology10.478370814.88
EquityTorrent Pharma.Pharmaceuticals & Biotechnology8.342568611.85
EquityAjanta PharmaPharmaceuticals & Biotechnology5.16209057.33
EquityDr Lal PathlabsHealthcare Services4.34323826.17
EquityMax HealthcareHealthcare Services4.00660545.68
EquityMankind PharmaPharmaceuticals & Biotechnology3.95225155.61
EquityNavin Fluo.Intl.Chemicals & Petrochemicals3.2653424.63
EquityAbbott IndiaPharmaceuticals & Biotechnology3.2217884.58
EquityManipal HealthHealthcare Services3.18676464.52
EquityNeuland Labs.Pharmaceuticals & Biotechnology2.8320444.02
EquityRubicon ResearchPharmaceuticals & Biotechnology2.73240703.87
EquitySai LifePharmaceuticals & Biotechnology2.64240863.75
EquityKrishna Institu.Healthcare Services2.58522473.66
EquityZydus Lifesci.Pharmaceuticals & Biotechnology2.45280053.48
EquityAster DM QualityHealthcare Services2.30478913.26
EquityIpca Labs.Pharmaceuticals & Biotechnology2.23164303.16
EquityDr Agarwal's EyeHealthcare Services2.2259303.15
EquityCiplaPharmaceuticals & Biotechnology2.11217312.99
EquityICICI LombardInsurance2.08186932.95
EquityGland PharmaPharmaceuticals & Biotechnology2.0192352.85
EquityLupinPharmaceuticals & Biotechnology1.89133802.69
EquityAnthem BiosciencPharmaceuticals & Biotechnology1.71293772.43
EquityFortis Health.Healthcare Services1.47272602.09
EquityJupiter Life LinHealthcare Services1.36749501.92
EquityGlobal HealthHealthcare Services1.30145511.84
EquitySymbiotec PharmaPharmaceuticals & Biotechnology1.07121581.51
EquityLenskart Solut.Retailing0.89187511.27
EquityMolbio DiagnostiHealthcare Equipment & Supplies0.7279771.01
EquityOrchid PharmaPharmaceuticals & Biotechnology0.68116650.97
EquitySagilityIT - Services0.471573640.66

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

MY WEALTH AT RETIREMENT

Calculate the worth of your wealth at retirement

Key information

Fund House:
PGIM India Mutual Fund
Incorporation Date:
24-Sep-2008
Total Assets Managed (Cr.):
27,858.82
Trustee/s:
PGIM India Trustees Priva
Chairman:
NA
CEO / MD:
Ajit Menon, Abhishek Tiwari
CIO:
NA
President:
NA
Director/s:
Mr.Indrasena Yala Reddy, Glenwyn Peter Baptist, Kapil Wadhawan, Mr.David Wan Chang, Dr. V. R. Narasimham, Mr.Muralidharan Rajamani
Compliance Officer/s:
Mr. Sumesh Kumar, Mr. Sandeep Kamath
Investor Service Officer/s:
Murali Ramasubramanian
Fund Manager/s:
Anandha Padmanabhan Anjen
Auditors:
NA

OTHER INFORMATION

Registered Office:
4th Floor, C Wing, Laxmi Towers, Bandra Kurla Complex, Bandra (East), Mumbai - 400 051
Contact Nos:
022-61593000
Fax:
022-61593100
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited. All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.